2025-04-25 - Analysis Report
## Public Storage (PSA) Stock Analysis Report

This report analyzes Public Storage (PSA), a self-storage real estate investment trust (REIT).

**1. Performance Comparison & Alpha/Beta Analysis:**

PSA's cumulative return (46.45%) significantly lags behind the S&P 500's (VOO) cumulative return (82.57%).  The current divergence is -36.1%, placing it at the 26.9th percentile of historical divergence based on the provided range.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 4.0% | 65.7% | -28.0% | 0.0 | 27.3 |
| 2016-2018  | -16.0% | 66.8% | -37.0% | -0.1 | 27.5 |
| 2017-2019  | 15.0% | 66.8% | -19.0% | -0.5 | 29.9 |
| 2018-2020  | 26.0% | 66.8% | -5.0% | 0.8 | 33.7 |
| 2019-2021  | 70.0% | 65.7% | 10.0% | 1.0 | 56.2 |
| 2020-2022  | 39.0% | 67.4% | 31.0% | 1.1 | 44.8 |
| 2021-2023  | 30.0% | 72.4% | 10.0% | 0.6 | 50.9 |
| 2022-2024  | -15.0% | 72.8% | -35.0% | 0.7 | 52.0 |
| 2023-2025  | -20.0% | 72.8% | -41.0% | 0.8 | 51.5 |

The Alpha values show periods of both underperformance and outperformance relative to the market (likely due to the beta being higher than 1 in some years), while the Beta indicates significant market sensitivity.  The substantial market capitalization (Cap(B)) suggests PSA is a significant player in the self-storage sector.

**2. Recent Price Movement:**

* **Closing Price:** $293.79
* **5-Day Moving Average:** $293.85
* **20-Day Moving Average:** $288.96
* **60-Day Moving Average:** $295.69

The price is slightly below its 5-day moving average, suggesting recent sideways or slightly downward price action. It's also below its 60-day moving average, indicating a potential short-term downtrend. The 20-day moving average being lower than the 5-day and 60-day moving averages is indicative of some price consolidation or slight downward momentum.  The recent price change shows a small decrease (-$0.49).

**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.4053 (Medium Risk)
* **RSI:** 49.45 (Near neutral; neither overbought nor oversold)
* **PPO:** 0.5764 (Positive, suggesting bullish momentum)
* **20-Day Relative Divergence Change:** -6.1% (Short-term downward trend)
* **Expected Return:** -44.1% (Long-term (2+ years) expected underperformance relative to the S&P 500)

The relatively low RSI suggests a neutral outlook and the PPO shows positive momentum that is counter to the other indicators. The negative expected return and recent price decrease warrant further investigation.

**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue     |
|------------|-------|-------------|
| 2024-10-30 | 2.17  | $1.19B      |
| 2024-07-30 | 2.67  | $1.17B      |
| 2024-04-30 | 2.61  | $1.16B      |
| 2023-10-30 | 3.21  | $1.14B      |
| 2024-10-30 | 3.21  | $1.14B      | *(Duplicate Entry)*


There's a noticeable decline in EPS from Q4 2023 to recent quarters.  Revenue remains relatively stable. The duplicate entry for October 2024 needs clarification. This earnings trend is concerning.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $1.18B | 73.61% |
| 2024-09-30 | $1.19B | 72.92% |
| 2024-06-30 | $1.17B | 74.34% |
| 2024-03-31 | $1.16B | 71.96% |
| 2023-12-31 | $1.16B | 74.93% |

Revenue is relatively consistent, with profit margins remaining high but showing slight fluctuations.


**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $9.71B | 6.33% |
| 2024-09-30 | $9.61B | 4.48% |
| 2024-06-30 | $9.71B | 5.34% |
| 2024-03-31 | $9.95B | 5.12% |
| 2023-12-31 | $10.01B | 4.39% |

Equity shows slight variation. ROE is also fluctuating, suggesting potential volatility in profitability.


**6. Overall Analysis:**

PSA's recent performance has underperformed the S&P 500, showing a considerable negative divergence. While the company maintains high profit margins and consistent revenue, declining EPS and mixed technical indicators raise concerns. The negative long-term expected return relative to the S&P 500, coupled with the recent price decrease, suggests caution. Further investigation into the reasons behind declining EPS and the duplicate earnings data point is crucial before making any investment decisions.  The high beta suggests significant market sensitivity which will likely lead to significant price volatility.  More in-depth fundamental analysis is needed to fully assess the investment potential of PSA.
